David R. Maraldo net worth and biography

David Maraldo Biography and Net Worth

EVP of Merck & Co., Inc.

Dave Maraldo is executive vice president and president, Merck Manufacturing Division. He has responsibility for the company’s worldwide human health manufacturing and supply operations across a global network of sites for pharmaceuticals, vaccines and biologics.

Since joining our company as a project engineer in 1999, he progressed through a range of leadership roles across manufacturing, technical operations, commercialization and integrated development and supply. Building on that foundation, he led global biologics operations from 2022- 2025 and most recently served as senior vice president of human health manufacturing.

An active champion of leadership development, Dave has served as the executive sponsor for the Society for Women Engineers and the American Institute of Chemical Engineers Future of STEM Scholars Initiative. He also contributes to several advisory boards, including the Widener University School of Engineering Board of Advisors and the William D. and Sherry L. Young Institute for the Advanced Manufacturing of Pharmaceuticals at Purdue University. He has also previously served on the NIBRT Training Advisory Board, a world-class institute that provides training and research solutions for the biopharmaceutical manufacturing industry, in addition to serving in an advisory role for Hilleman Laboratories.

Dave earned his Ph.D. and master of chemical engineering degrees from Drexel University, an MBA degree from Lehigh University and a bachelor of chemical engineering degree from Widener University.

What is David R. Maraldo's net worth?: The estimated net worth of David R. Maraldo is at least $2.38 million as of August 5th, 2026. Maraldo owns 18,212 shares of Merck & Co., Inc. stock worth more than $2,375,828 as of August 10th. This net worth evaluation does not reflect any other investments that Maraldo may own. Learn More about David R. Maraldo's net worth.
How do I contact David R. Maraldo?: The corporate mailing address for Maraldo and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at [email protected]. Learn More on David R. Maraldo's contact information.
Has David R. Maraldo been buying or selling shares of Merck & Co., Inc.?: Within the last three months, David R. Maraldo has sold $2,407,836.32 in Merck & Co., Inc. stock. Most recently, David R. Maraldo sold 18,706 shares of the business's stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $128.72, for a transaction totalling $2,407,836.32. Following the completion of the sale, the executive vice president now directly owns 18,212 shares of the company's stock, valued at $2,344,248.64. Learn More on David R. Maraldo's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Chirfi Guindo (CMO), Michael Holston (EVP), E III (SVP), Rita Karachun (VP), Dean Li (VP), Caroline Litchfield (CFO), David Maraldo (EVP), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), Wendell Weeks (Director), David Williams (Executive vice president, chief information & digital officer), and Jennifer Zachary (EVP). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, insiders at the sold shares 14 times. They sold a total of 415,343 shares worth more than $50,179,723.44. The most recent insider tranaction occured on August, 6th when EVP Chirfi Guindo sold 15,000 shares worth more than $1,965,000.00. Insiders at Merck & Co., Inc. own 0.2% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 8/6/2026.

David R. Maraldo Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/5/2026	Sell	18,706	$128.72	$2,407,836.32	18,212

David R. Maraldo Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $130.52

$128.24

$130.98

50 Day Range

MA: $123.98

$114.04

$131.85

2 Week Range

Now: $130.52

$77.58

$135.05

Volume

1,957,887 shs

Average Volume

10,713,943 shs

Market Capitalization

$322.35 billion

P/E Ratio

104.45

Dividend Yield

2.64%

Beta

0.19